AU2003210062A1 - Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof - Google Patents

Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof

Info

Publication number
AU2003210062A1
AU2003210062A1 AU2003210062A AU2003210062A AU2003210062A1 AU 2003210062 A1 AU2003210062 A1 AU 2003210062A1 AU 2003210062 A AU2003210062 A AU 2003210062A AU 2003210062 A AU2003210062 A AU 2003210062A AU 2003210062 A1 AU2003210062 A1 AU 2003210062A1
Authority
AU
Australia
Prior art keywords
gonadotropin
agonists
antagonists
releasing hormone
hormone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003210062A
Inventor
Hyuk-Bang Kwon
Jae-Young Seong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003210062A1 publication Critical patent/AU2003210062A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003210062A 2002-05-03 2003-03-24 Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof Abandoned AU2003210062A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20020024423 2002-05-03
KR10-2002-0024423 2002-05-03
PCT/KR2003/000572 WO2003093304A1 (en) 2002-05-03 2003-03-24 Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof

Publications (1)

Publication Number Publication Date
AU2003210062A1 true AU2003210062A1 (en) 2003-11-17

Family

ID=36596818

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003210062A Abandoned AU2003210062A1 (en) 2002-05-03 2003-03-24 Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof

Country Status (4)

Country Link
US (1) US7285528B2 (en)
KR (1) KR100808921B1 (en)
AU (1) AU2003210062A1 (en)
WO (1) WO2003093304A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8334258B2 (en) * 2005-07-26 2012-12-18 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts (Universitätsmedizin) Method for induction and enhancement of apoptosis in tumor cells
GB0616111D0 (en) 2006-06-16 2006-09-20 Ardana Bioscience Ltd Agents, methods and uses
US20100061976A1 (en) * 2008-07-24 2010-03-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject
US20120004182A1 (en) 2010-07-02 2012-01-05 Carsten Gruendker Pharmaceutical compositions and methods for induction and enhancement of apoptosis in tumor cells
KR101403112B1 (en) 2012-03-09 2014-06-03 호서대학교 산학협력단 Peptide for suppression of cancer cell
CN108503695B (en) * 2018-03-09 2021-06-08 南方医科大学南方医院 Tracer based on GnRH polypeptide derivative and preparation method and application thereof
AU2020265451A1 (en) * 2019-05-02 2021-12-23 The University Of Sydney Peptide derivatives and conjugates thereof for treating cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2029018A1 (en) * 1989-11-01 1991-05-02 Robert P. Millar Analogues of gonadotropin releasing hormone

Also Published As

Publication number Publication date
KR100808921B1 (en) 2008-03-03
KR20050008696A (en) 2005-01-21
US20060135432A1 (en) 2006-06-22
US7285528B2 (en) 2007-10-23
WO2003093304A1 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
AU2003265853A1 (en) Hedgehog antagonists, methods and uses related thereto
AU2003261723A1 (en) Cxcr4 antagonist and use thereof
ZA200409333B (en) 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2B and alpha-2C adrenergic receptors.
EP3308772B8 (en) Inhalable epinephrine
MXPA03009220A (en) Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors.
SI1455785T1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
AU2003238597A1 (en) Benzimidazole compounds and their use as estrogen agonists/antagonists
AU2003252478A1 (en) Ccr4 antagonist and medicinal use thereof
HK1079518A1 (en) Quinazolinone derivatives and their use as cb agonists
AU2003219914A1 (en) Intranasal administration of mc4-r agonists
HK1088910A1 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
AU2003224747A1 (en) Technetium-labeled rotenone derivatives, and methods of use thereof
AU2003277215A1 (en) Novel neurokinin antagonists and methods of use thereof
AU2003279841A1 (en) Uses of human zven antagonists
AU2003260072A1 (en) Antagonists of chemokine receptors
AU2003299943A1 (en) Heterocycles and uses thereof
AU2003210062A1 (en) Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof
AU2003233127A1 (en) Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
AU2003277925A1 (en) Sprayable coating agent and production, further processing, and use thereof
AU2002302735A1 (en) 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists
AU2002368487A1 (en) Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists
ZA200403530B (en) Chemokine receptor antagonists and methods of use thereof.
AU2003296871A1 (en) Point feeder and use of point feeder
AU2003300396A1 (en) Chemokine antagonists and uses thereof
AU2003300122A1 (en) Agonists and antagonists of the human odorant receptor or17-4 and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase